BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12632104)

  • 61. Augmentation of tumor necrosis factor family-induced apoptosis by E3330 in human hepatocellular carcinoma cell lines via inhibition of NF kappa B.
    Saitou Y; Shiraki K; Yamanaka T; Miyashita K; Inoue T; Yamanaka Y; Yamaguchi Y; Enokimura N; Yamamoto N; Itou K; Sugimoto K; Nakano T
    World J Gastroenterol; 2005 Oct; 11(40):6258-61. PubMed ID: 16419152
    [TBL] [Abstract][Full Text] [Related]  

  • 62. BRCA1-mediated inflammation and growth activated & inhibited transition mechanisms between no-tumor hepatitis/cirrhotic tissues and HCC.
    Diao H; Wang L; Huang J; Jiang M; Zhou H; Li X; Chen Q; Jiang Z; Feng H
    J Cell Biochem; 2014 Apr; 115(4):641-50. PubMed ID: 24151232
    [TBL] [Abstract][Full Text] [Related]  

  • 63. WHO grade related expression of TRAIL-receptors and apoptosis regulators in meningioma.
    Koschny R; Krupp W; Xu LX; Mueller WC; Bauer M; Sinn P; Keller M; Koschny T; Walczak H; Bruckner T; Ganten TM; Holland H
    Pathol Res Pract; 2015 Feb; 211(2):109-16. PubMed ID: 25481563
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Human mast cells undergo TRAIL-induced apoptosis.
    Berent-Maoz B; Piliponsky AM; Daigle I; Simon HU; Levi-Schaffer F
    J Immunol; 2006 Feb; 176(4):2272-8. PubMed ID: 16455983
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chloroquine upregulates TRAIL/TRAILR2 expression and potentiates doxorubicin anti-tumor activity in thioacetamide-induced hepatocellular carcinoma model.
    Helmy SA; El-Mesery M; El-Karef A; Eissa LA; El Gayar AM
    Chem Biol Interact; 2018 Jan; 279():84-94. PubMed ID: 29133031
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax.
    Liang X; Liu Y; Zhang Q; Gao L; Han L; Ma C; Zhang L; Chen YH; Sun W
    J Immunol; 2007 Jan; 178(1):503-10. PubMed ID: 17182590
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Altered regulation of extrinsic apoptosis pathway in HCV-infected HCC cells enhances susceptibility to mapatumumab-induced apoptosis.
    Zhang X; Frank AC; Gille CM; Daucher M; Kabat J; Becker S; Lempicki RA; Cortez KJ; Polis MA; Subramanian GM; Kottilil S
    Hepatol Res; 2009 Dec; 39(12):1178-89. PubMed ID: 19788693
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression of apoptosis- and vitamin D pathway-related genes in hepatocellular carcinoma.
    Fingas CD; Altinbas A; Schlattjan M; Beilfuss A; Sowa JP; Sydor S; Bechmann LP; Ertle J; Akkiz H; Herzer K; Paul A; Gerken G; Baba HA; Canbay A
    Digestion; 2013; 87(3):176-81. PubMed ID: 23635474
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mutation analysis and mRNA expression of trail-receptors in human breast cancer.
    Seitz S; Wassmuth P; Fischer J; Nothnagel A; Jandrig B; Schlag PM; Scherneck S
    Int J Cancer; 2002 Nov; 102(2):117-28. PubMed ID: 12385006
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers.
    Shin MS; Kim HS; Lee SH; Park WS; Kim SY; Park JY; Lee JH; Lee SK; Lee SN; Jung SS; Han JY; Kim H; Lee JY; Yoo NJ
    Cancer Res; 2001 Jul; 61(13):4942-6. PubMed ID: 11431320
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression of tumor necrosis factor--related apoptosis-inducing ligand receptors 1 and 2 in melanoma.
    McCarthy MM; DiVito KA; Sznol M; Kovacs D; Halaban R; Berger AJ; Flaherty KT; Camp RL; Lazova R; Rimm DL; Kluger HM
    Clin Cancer Res; 2006 Jun; 12(12):3856-63. PubMed ID: 16778114
    [TBL] [Abstract][Full Text] [Related]  

  • 72. PTHLH coupling upstream negative regulation of fatty acid biosynthesis and Wnt receptor signal to downstream peptidase activity-induced apoptosis network in human hepatocellular carcinoma by systems-theoretical analysis.
    Huang J; Wang L; Jiang M; Lin H; Qi L; Diao H
    J Recept Signal Transduct Res; 2012 Oct; 32(5):250-6. PubMed ID: 22799769
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Correlation between TRAIL and caspase-8 expression and their relationship with cell proliferation and apoptosis in human osteosarcoma.
    Ning X; Shang XW; Zhuang Y; Liu M; Yang H; Zhang H; Huang MZ
    Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 28002586
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Expression of TRAIL (TNF-related apoptosis-inducing ligand) receptors in cervical cancer.
    Ryu HS; Chang KH; Chang SJ; Kim MS; Joo HJ; Oh KS
    Int J Gynecol Cancer; 2000 Sep; 10(5):417-424. PubMed ID: 11240708
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mutation of the DR5/TRAIL receptor 2 gene is infrequent in hepatocellular carcinoma.
    Jeng YM; Hsu HC
    Cancer Lett; 2002 Jul; 181(2):205-8. PubMed ID: 12175536
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Apoptosis induction by TRAIL.
    Eggert A; Sieverts H; Walczak H
    Methods Mol Biol; 2003; 215():95-116. PubMed ID: 12512293
    [No Abstract]   [Full Text] [Related]  

  • 77. E2 of hepatitis C virus inhibits apoptosis.
    Lee SH; Kim YK; Kim CS; Seol SK; Kim J; Cho S; Song YL; Bartenschlager R; Jang SK
    J Immunol; 2005 Dec; 175(12):8226-35. PubMed ID: 16339562
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The lncRNA CASC2 Modulates Hepatocellular Carcinoma Cell Sensitivity and Resistance to TRAIL Through Apoptotic and Non-Apoptotic Signaling.
    Sun J; Xu H; Lei Z; Li Z; Zhu H; Deng Z; Yu X; Jin X; Yang Z
    Front Oncol; 2021; 11():726622. PubMed ID: 35145900
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Apoptosis induced by nucleosides in the human hepatoma HepG2.
    Yang SC; Chiu CL; Huang CC; Chen JR
    World J Gastroenterol; 2005 Oct; 11(40):6381-4. PubMed ID: 16419169
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antitumor Effect of Periplocin in TRAIL-Resistant Human Hepatocellular Carcinoma Cells through Downregulation of IAPs.
    Cheng CF; Lu IH; Tseng HW; Sun CY; Lin LT; Kuo ZK; Pan IH; Ko CH
    Evid Based Complement Alternat Med; 2013; 2013():958025. PubMed ID: 23365613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.